Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
8.78
+0.91 (11.56%)
Nov 22, 2024, 4:00 PM EST - Market closed
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $502.72 million as of November 22, 2024. Its market cap has decreased by -46.30% in one year.
Market Cap
502.72M
Enterprise Value
289.66M
1-Year Change
-46.30%
Ranking
Category
Stock Price
$8.78
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $502.72M, a decrease of -71.99%. That is a compound annual growth rate of -27.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 450.62M | -41.20% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 478.78M |
| REGENXBIO | 477.12M |
| Terns Pharmaceuticals | 475.66M |
| Esperion Therapeutics | 474.85M |
| Celcuity | 474.52M |
| Y-mAbs Therapeutics | 472.08M |
| OmniAb | 471.95M |
| Pacific Biosciences of California | 471.05M |